European digital health is moving decisively from experimentation to execution, driven by regulation, scale, and market discipline.
Key signals shaping the next phase:

• EHDS establishes a clear path toward a single EU digital health market, with March 2029 as a defining milestone
• Digital Twins are transitioning from research environments to clinical validation and commercial application
• Pharma–Healthtech convergence is accelerating through M&A and strategic partnerships
• AI in clinical practice is now widespread, yet governance, accountability, and workforce training remain uneven
• Reimbursement and evidence requirements continue to be the primary constraints on market access

The opportunity is substantial, but outcomes will be determined by execution. Market access will depend on regulatory strategy, evidence generation aligned with EU standards, and early integration with EHDS frameworks.

At Strategic Healthcare Advisors, we focus on exactly this intersection—supporting innovators, investors, and corporates in translating digital health innovation into scalable, compliant, and reimbursable solutions.